Malaria News and Research

Latest Malaria News and Research

Pneumonia Report Card shows prevention, treatment tools not widely adopted in countries where disease kills most children

In advance of World Pneumonia Day, the International Vaccine Access Center (IVAC) on Thursday released a report card showing that pneumonia prevention and intervention targets are not being met in the 15 countries where three-quarters of deaths in children under age 5 from the disease occur each year, IRIN reports.

14 Nov 2010

Inovio to update HVTN 080 Phase I clinical study for HIV at HVTN Conference

Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that Dr. Spyros Kalams will provide an update of interim immune responses and safety results from the HVTN 080 Phase I clinical study of Inovio's PENNVAX-B HIV DNA vaccine in a preventive setting.

12 Nov 2010

Urgent action needed to prevent and treat childhood pneumonia

A Pneumonia Report Card released today by the International Vaccine Access Center (IVAC) on behalf of the Global Coalition against Child Pneumonia reveals where urgent efforts are needed to reach target levels of coverage for the life-saving interventions that can prevent, protect against and treat pneumonia in children.

12 Nov 2010

G20 summit opens in Seoul; development plan announcement expected

The world's biggest rich and emerging powers escalated a war of words over trade and currencies Thursday, as leaders opened a G20 summit [in Seoul, South Korea] struggling to iron out distortions that threaten global growth, Agence France-Presse reports in an article examining some of the major disputes.

11 Nov 2010

New insect control method can bring decline in malaria-bearing mosquitoes

Research carried out in Mali, West Africa, has demonstrated that a new, safe and uncomplicated insect control method, developed at the Hebrew University of Jerusalem, can bring about a serious decline in malaria-bearing mosquitoes in afflicted regions in the world.

11 Nov 2010

Pevion announces positive results of PEV7 Phase I study for recurrent vulvovaginal candidiasis

Pevion Biotech AG today announced positive preliminary results from a Phase I study of PEV7, the first vaccine against recurrent vulvovaginal candidiasis (RVVC).

11 Nov 2010

Portugal research groups awarded Gates Foundation grants

Two research groups in Portugal are to receive Grand Challenges Exploration Grants from the Bill & Melinda Gates Foundation. One of these research teams is led by Miguel Prud-ncio, at the Instituto de Medicina Molecular (IMM), and the other by Miguel Soares, at the Instituto Gulbenkian de Ci-ncia (IGC) together with Henrique Silveira, at the Instituto de Higiene e Medicina Tropical (IHMT).

11 Nov 2010

NJIT expert to discuss history of sickle cell disease at NIH symposium

The history of sickle cell disease in the 20th century and its link to race is the focus of a Nov. 16, 2010 talk at a national symposium by NJIT Associate Professor Stephen Pemberton, PhD, an expert on the history of diseases. Pemberton will speak and join a panel discussion at the National Institutes of Health (NIH), Bethesda, 100th anniversary symposium commemorating the discovery of sickle cell disease by Chicago physician James B. Herrick.

11 Nov 2010

UC Riverside to design ultra-cheap sensors to fight malaria with $100,000 Gates Foundation grant

The University of California, Riverside announced today that it has received a $100,000 Grand Challenges Explorations grant from the Bill & Melinda Gates Foundation. The grant will support an innovative global health research project conducted by Eamonn Keogh, a professor of computer science and engineering in the Bourns College of Engineering, titled "Counting and classifying insects with ultra-cheap sensors."

11 Nov 2010

New 'magic bullet' can eradicate side effects of drug used to treat cystinosis

A 'magic bullet' designed by pharmaceutical scientists at an English university could eradicate the side effects of a drug used to treat a rare genetic disease. Researchers at the University of Sunderland have chemically modified a drug used to treat cystinosis a disease which occurs when the body's mechanism to remove excess cystine (an amino acid) breaks down, leading to kidney problems and eventually affecting other organs to remove unpleasant side effects such as nausea, vomiting, severe halitosis, body odour and a noxious taste.

11 Nov 2010

Opinions: G20 development approach; defense of DDT for malaria control; U.S. foreign aid; human trafficking

Leaders have been debating how to 'rebalance' the global economy and reform financial institutions - all challenging subjects. But I also am reminding my colleagues that all these goals, however crucial, are insufficient, Lee Myung-bak, the president of the Republic of Korea, writes in a Washington Post opinion piece.

10 Nov 2010

Malaria drug artesunate found more effective than quinine at preventing severe falciparum malaria deaths in children, study says

Researchers found that the death rate among children diagnosed with severe falciparum malaria was almost one-fourth lower when they received the drug artesunate rather than the standard treatment of quinine, according to research which was presented at the American Society for Tropical Medicine and Hygiene (ASTMH) over the weekend and published Monday in the Lancet, HealthDay News/U.S. News and World Report writes.

10 Nov 2010

World Lung Foundation report highlights prevalence of acute respiratory infections worldwide

Acute respiratory infections (ARIs) - such as influenza, pneumonia and respiratory syncytial virus (RSV) - cause 4.25 million deaths each year often among young children in developing countries, according to the Acute Respiratory Infections Atlas, which was released on Tuesday by the World Lung Foundation, Reuters reports (11/9).

10 Nov 2010

Research demonstrates a safe method to control malaria in Africa

9 Nov 2010

Fake antimalarial medications uncovered across Ghana

Substandard and counterfeit versions of thirteen key antimalarial medicines were uncovered in multiple locations across Ghana by the Medicines Quality Monitoring surveillance program. Set up by the Ghana Food and Drugs Board (FDB) in collaboration with the U.S. Pharmacopeial Convention (USP) and the U.S. Agency for International Development (USAID), the program samples antimalarials across the public and private sectors.

9 Nov 2010

Research reveals body’s defence mechanism against snail fever

Scientists have made a significant discovery about how the body defends itself against snail fever, a parasitic worm infection common in developing countries.

9 Nov 2010

Africare announces $1.42M grant from ExxonMobil for battle against malaria in Africa

Africare President Darius Mans announced today new investments from ExxonMobil to extend their partnership in its fight against malaria. ExxonMobil, which has long been a supporter of Africare, will fund three key malaria prevention and intervention programs in Africa.

9 Nov 2010

New Yorker examines global TB diagnostic challenges

The New Yorker examines the challenges associated with treating tuberculosis across the world and looks at whether a rapid diagnostic test could prevent millions of deaths from the disease.

8 Nov 2010

Pres. Obama, Indian PM Singh announce partnership to improve global food security

During a joint press conference with Indian Prime Minister Manmohan Singh on Monday, President Barack Obama announced a new partnership between U.S. and Indian agriculture sectors to help improve food security globally, Press Trust International/Livemint.com reports.

8 Nov 2010

TB Alliance launches three-drug combination trial for drug-sensitive and multidrug-resistant TB

In advance of the 41st Union World Conference, the Global Alliance for TB Drug Development (TB Alliance) today announced the launch of the first clinical trial to test a novel tuberculosis regimen in a new development paradigm designed to speed new treatments to patients. This novel three-drug combination shows promise to treat both drug-sensitive (DS-TB) and multidrug-resistant TB (MDR-TB), and alter the course of the TB pandemic by shortening and simplifying treatment worldwide.

8 Nov 2010

Malaria News and Research

Latest Malaria News and Research

Pneumonia Report Card shows prevention, treatment tools not widely adopted in countries where disease kills most children

Inovio to update HVTN 080 Phase I clinical study for HIV at HVTN Conference

Urgent action needed to prevent and treat childhood pneumonia

G20 summit opens in Seoul; development plan announcement expected

New insect control method can bring decline in malaria-bearing mosquitoes

Pevion announces positive results of PEV7 Phase I study for recurrent vulvovaginal candidiasis

Portugal research groups awarded Gates Foundation grants

NJIT expert to discuss history of sickle cell disease at NIH symposium

UC Riverside to design ultra-cheap sensors to fight malaria with $100,000 Gates Foundation grant

New 'magic bullet' can eradicate side effects of drug used to treat cystinosis

Opinions: G20 development approach; defense of DDT for malaria control; U.S. foreign aid; human trafficking

Malaria drug artesunate found more effective than quinine at preventing severe falciparum malaria deaths in children, study says

World Lung Foundation report highlights prevalence of acute respiratory infections worldwide

Research demonstrates a safe method to control malaria in Africa

Fake antimalarial medications uncovered across Ghana

Research reveals body’s defence mechanism against snail fever

Africare announces $1.42M grant from ExxonMobil for battle against malaria in Africa

New Yorker examines global TB diagnostic challenges

Pres. Obama, Indian PM Singh announce partnership to improve global food security

TB Alliance launches three-drug combination trial for drug-sensitive and multidrug-resistant TB

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Malaria News and Research

Latest Malaria News and Research

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in